AI in Mental Health: Why Clinicians Need to Be in the Room
As clinicians, we learn not to be agreeable, we learn to challenge and sit in…
AI in Mental Health: Why Clinicians Need to Be in the Room
As clinicians, we learn not to be agreeable, we learn to challenge and sit in discomfort. We ask the hard questions underneath the one being asked. That is the work these tools are not yet built to do. The post AI in Mental Health: Why Clinicians Need to Be in the Room appeared first on…
When Evidence Gap Becomes a Commercial Liability
The MENA evidence gap for selected portfolios is becoming a commercial liability for drugmakers that could have been prevented at the design stage. The post When Evidence Gap Becomes a Commercial Liability appeared first on MedCity News.
Journalists Discuss Healthcare Costs’ Political Fallout, Concerns About Canceled ICE Facility
KFF Health News senior correspondent Julie Appleby discussed the high cost of healthcare and the political fallout on WAMU’s 1A on June 30. Click here to hear Appleby on 1A. KFF Health News senior correspondent Renuka Rayasam discussed the public health concerns around a planned immigration detention center in Georgia on WUGA’s The Georgia Health…
July 4, 1862
By MIKE MAGEE When I asked my brilliant literary agent, Jill Kneerim, when I would know that my book proposal was ready for submission, she replied directly, “It will be ready when I say it is ready.” Eleven months later, in April, 2018, she finally green lit the project, and two weeks after that, in…
This Ear-Based Device Could Save Patients from Brain Bleed Complications
Aurenar’s V-Link, a non-invasive nerve stimulation device for preventing brain hemorrhage complications, just won FDA breakthrough device designation after early trials showed it cut cerebral vasospasm by more than 40%. The post This Ear-Based Device Could Save Patients from Brain Bleed Complications appeared first on MedCity News.
Color Broadens Cancer Expert Medical Opinion Program
Color expanded its Expert Medical Opinion program with a new peer-to-peer service that connects oncologists with cancer specialists. The post Color Broadens Cancer Expert Medical Opinion Program appeared first on MedCity News.
With New Phase 3 Data, Roche Claims an Edge Over Amgen and BMS Lung Cancer Drugs
Roche’s divarasib was designed offer greater potency and selectivity to KRAS G12C compared to first-generation drugs in this class marketed by Amgen and Bristol Myers Squibb. The Swiss pharma company now plans to submit the data to regulators for review as a potential treatment for non-small cell lung cancer driven by this particular mutated protein….
Debunked Episode 28: A Little More Transparency, A Little More Action
Debunked Podcast co-hosts Arundhati Parmar and Samir Batra discussed some of the takeaways from UnitedHealth Group’s press event, transparency, and pharma company Lilly’s efforts to hold hospitals accountable in 340B drug discount program. The post Debunked Episode 28: A Little More Transparency, A Little More Action appeared first on MedCity News.
Hospital Networks are Becoming Targets in Cyberwarfare, and They’re Unequipped to Deal With It
The question facing hospital cybersecurity leaders today is no longer whether they will be collateral damage in a broader war; it’s how to reckon with adversaries who will target healthcare for ideological or political reasons — hackers may not have any particular interest in quick resolutions. The post Hospital Networks are Becoming Targets in Cyberwarfare,…
